An Evaluation of a Novel Dual Treponemal/Nontreponemal Point-of-Care Test for Syphilis as a Tool to Distinguish Active From Past Treated Infection
Author(s) -
Louise Causer,
John Kaldor,
Damian P. Conway,
David Leslie,
Ian Denham,
Theo Karapanagiotidis,
Claire Ryan,
Handan Wand,
David A. Anderson,
Peter W. Robertson,
Anna McNulty,
Basil Donovan,
Christopher K. Fairley,
Rebecca Guy
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ243
Subject(s) - medicine , syphilis , rapid plasma reagin , concordance , point of care testing , confidence interval , point of care , serology , titer , syphilis serodiagnosis , immunology , antibody , pathology , treponema , human immunodeficiency virus (hiv)
Most syphilis point-of-care (POC) tests detect treponemal antibodies, which persist after successful treatment. Subsequent POC tests are positive, despite no active infection, and can lead to unnecessary treatment. We evaluated a new POC test, incorporating a nontreponemal component, to distinguish active from past infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom